UNITED THERAPEUTICS Corp — Director's Dealing 2021

Nov 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-11-04

Reporting Person: MAHON PAUL A (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	M	6000	$111.00	Acquired	42369	Direct
2021-11-04	Common Stock	S	3800	$200.6492	Disposed	38569	Direct
2021-11-04	Common Stock	S	1400	$201.8386	Disposed	37169	Direct
2021-11-04	Common Stock	S	800	$202.64	Disposed	36369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Stock Options	$111.00	M	6000	Disposed	2028-03-15	Common Stock (6000)	Direct

Footnotes

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $200.1050 to 200.9850. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $201.51 to $202.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.